Littleton, Massachusetts, United States, December 2024 – Sandra Rousselle has been promoted to Vice President, People Operations & Public Affairs at Mevion Medical Systems, a leading provider of proton therapy systems for cancer treatment. In this expanded role, Sandra will continue driving the organization’s HR strategies while also spearheading public affairs initiatives to strengthen Mevion’s global presence and commitment to healthcare innovation.
Sandra joined Mevion Medical Systems in 2018 as Senior Director of Human Resources, where she contributed significantly to the organization’s talent development and operational excellence. She was later promoted to Vice President of People Operations, where she led transformative HR initiatives and fostered a strong organizational culture aligned with Mevion’s mission and values.
Prior to her tenure at Mevion, Sandra served as Director of Human Resources at Advanced Instruments, LLC, where she implemented strategic HR systems, improved compliance, and enhanced performance management processes. Her earlier experience includes impactful roles at Fresenius Medical Care, where she partnered with leadership on talent development and organizational restructuring, and at Hollingsworth & Vose, where she led HR initiatives for union and non-union operations across North America.
Sandra’s career also includes HR leadership positions at Schweitzer-Mauduit International Inc. and Advanced Refractory Technologies, Inc., where she successfully managed HR operations, compliance, and employee relations.
About Mevion Medical Systems
Founded in Littleton, Massachusetts, Mevion Medical Systems is a pioneer in the field of proton therapy, providing innovative systems for radiation treatment of cancer patients. The company’s flagship product line, the MEVION S250 Series, features cutting-edge technologies designed to deliver efficient, precise, and cost-effective cancer treatments.
With international offices in the United Kingdom, Japan, and a joint venture in China, Mevion is dedicated to making proton therapy accessible and scalable for cancer centers worldwide. The company’s commitment to innovation and quality has positioned it as a leader in the fight against cancer.
Read Also : Entering 2025, TA Leaders’ Success Built on More than Just Hiring, Says The Josh Bersin Company
People Analytics Teams Still Struggle to Deliver Business Impact, Warns The Josh Bersin Company
ESG and Women’s Leadership: Driving Sustainability and Inclusion
Learning and Development Trends for 2025: Shaping the Future of Workplace Learning
